|
(ÁÖ)¿¤¾ØÄÉÀ̹ÙÀÌ¿À¸Þµå |
ÀÇ·á±â±â RA ´ã´çÀÚ ¸ðÁý
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
ÀÓ»óº´¸®»ç |
3³â¡è |
ä¿ë½Ã |
12.04 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Sales Team Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
7³â¡è |
ä¿ë½Ã |
12.04 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] QC Project management
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
ǰÁú°ü¸®/ǰÁúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
09.19 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] QC Project management
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
ǰÁú°ü¸®/ǰÁúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
09.09 |
|
|
(ÁÖ)´Ùº¹ |
2019³â ¿µ¾÷Á÷ ½ÅÀÔ ¹× °æ·Â»ç¿ø ä¿ë
°æ±â ÀüÁö¿ª, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.10 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç  |
Çѱ¹MSD CRA 0¸í ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
05.10 |
|
|
YGÄÄÆÛ´Ï |
Á¦¾à¿µ¾÷ ½ÅÀÔ ¸ðÁý
ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
06.29 |
|
|
PRA Health Sciences |
[PRA Health Sciences] CRA I, II, III, Drug Safety Associ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
06.28 |
|
|
DKSH Korea Ltd. |
Rx/Pharma Marketing Specialist (Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
06.13 |
|
|
(ÁÖ)¾ËÆÄ¸Þµå |
ÃÊÀ½ÆÄÁø´Ü±â¹× Áø´ÜÀåºñ ¿µ¾÷ °æ·ÂÁ÷ ¸ðÁý
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
»ó½Ãä¿ë |
09.25 |
|
|
(ÁÖ)¸Þµð½êÀÌ |
°æ±â ÀÇÁ¤ºÎ½Ã | ´ëÇÐ(4³â) ÀçÇÐ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.19 |
|
|
BMM KOREA |
ȯÀÚ±³À°ÇÁ·Î±×·¥À» ±âȹ.¸¶ÄÉÆÃ´ã´ç ÆÀÀ屸ÀÎ
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
03.21 |
|
|
(ÁÖ)¸ß¾ÆÀ̾¾¿¡½º |
ÇØ¿Ü¿µ¾÷ °æ·ÂÀÚ ¸ðÁý
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
5³â¡è |
ä¿ë½Ã |
01.03 |
|
|
ÁÖ)ÈÞÅÛ  |
HUTEM ¸¶ÄÉÆÃ(PM) ¸ðÁý
°æ±â °í¾ç½Ã ´ö¾ç±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.19 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ¶ô¼¿ ÄÚ¸®¾Æ-CRA/Sr.CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.14 |
|